{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T14:25:56Z","timestamp":1790259956155,"version":"4.1.0"},"reference-count":18,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T00:00:00Z","timestamp":1734652800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:p>A female patient in middle childhood was diagnosed with coarctation of the aorta at one month of age and underwent a successful cortectomy. At 11 years old, she developed re-coarctation, which was managed through interventional cardiology. Shortly after the procedure, she experienced a sudden and severe clinical decline, presenting with hypoperfusion of the lower extremities, gastrointestinal bleeding, acute kidney injury, and pancreatitis. Multiple thrombotic events were identified, prompting an extensive evaluation for thrombophilia<jats:bold>.<\/jats:bold> The patient tested positive for antiphospholipid antibodies and was diagnosed with catastrophic antiphospholipid antibody syndrome (CAPS). An aggressive treatment was initiated, yielding a favorable response following discharge; she made a full recovery and continues to be monitored regularly in cardiology and rheumatology clinics.<\/jats:p>","DOI":"10.3389\/fped.2024.1410400","type":"journal-article","created":{"date-parts":[[2024,12,23]],"date-time":"2024-12-23T11:11:57Z","timestamp":1734952317000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Case Report: Catastrophic antiphospholipid syndrome in a pediatric patient after percutaneous treatment of aortic re-coarctation"],"prefix":"10.3389","volume":"12","author":[{"given":"Iris Paola","family":"Garc\u00eda Herrera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Canales Robredo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Aboytes Zavala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Merayo Chalico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orfanel Sebastian","family":"Pineda Arzate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Luis","family":"Col\u00edn Ort\u00edz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis Alberto","family":"Aparicio Vera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,12,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1370843","DOI":"10.3389\/fped.2024.1370843","article-title":"Primary catastrophic antiphospholipid syndrome in children with midbrain infarction: a case report","volume":"12","author":"Dong","year":"2024","journal-title":"Front Pediatr"},{"key":"B2","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s11926-020-0887-9","article-title":"Pediatric APS: state of the art","volume":"22","author":"Soybilgic","year":"2020","journal-title":"Curr Rheumatol Rep"},{"key":"B3","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1055\/s-0043-1764472","article-title":"Pediatric presentation of antiphospholipid syndrome: a review of recent literature with estimation of local prevalence","volume":"50","author":"Radin","year":"2024","journal-title":"Semin Thromb Hemost"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1136\/ard.2004.025759","article-title":"Validation of the preliminary criteria for the classification of catastrophic antiphospholipid syndrome","volume":"64","author":"Cervera","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1056\/NEJMra1112830","article-title":"The pathogenesis of the antiphospholipid syndrome","volume":"368","author":"Giannakopoulos","year":"2013","journal-title":"N Engl J Med"},{"key":"B6","first-page":"478","article-title":"Complications of cardiac catheterization in pediatric patients: a single center experience","volume":"54","author":"Yilmazer","year":"2012","journal-title":"Turk J Pediatr"},{"key":"B7","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1002\/ccd.21580","article-title":"Complications of pediatric cardiac catheterization: a review in the current era","volume":"72","author":"Mehta","year":"2008","journal-title":"Catheter Cardiovasc Interv"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1016\/j.autrev.2016.09.010","article-title":"Catastrophic antiphospholipid syndrome (CAPS): descriptive analysis of 500 patients from the international CAPS registry","volume":"15","author":"Rodriguez-Pint\u00f3","year":"2016","journal-title":"Autoimmun Rev"},{"key":"B9","doi-asserted-by":"publisher","first-page":"77","DOI":"10.5455\/apr.051720141800","article-title":"Pediatric catastrophic antiphospholipid syndrome: case study and literature review","volume":"3","author":"Defreitas","year":"2014","journal-title":"Ann Paediatr Rheum"},{"key":"B10","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1191\/0961203303lu394oa","article-title":"Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines","volume":"12","author":"Asherson","year":"2003","journal-title":"Lupus"},{"key":"B11","doi-asserted-by":"publisher","first-page":"17103","DOI":"10.1038\/nrdp.2017.103","article-title":"Antiphospholipid syndrome","volume":"11","author":"Schreiber","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"B12","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.semarthrit.2006.09.003","article-title":"Intestinal involvement secondary to the antiphospholipid syndrome (APS): clinical and immunologic characteristics of 97 patients: comparison of classic and catastrophic APS","volume":"36","author":"Cervera","year":"2007","journal-title":"Semin Arthritis Rheum"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1136\/annrheumdis-2016-211001","article-title":"European evidence-based recommendations for diagnosis and treatment of pediatric antiphospholipid syndrome: the SHARE 267 initiative","volume":"76","author":"Groot","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"B14","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1097\/BOR.0000000000000426","article-title":"The catastrophic antiphospholipid syndrome in children","volume":"29","author":"Go","year":"2017","journal-title":"Curr Opin Rheumatol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"9","DOI":"10.12860\/jnp.2014.03","article-title":"Catastrophic antiphospholipid syndrome: a clinical review","volume":"3","author":"Nayer","year":"2014","journal-title":"J Nephropathol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.5858\/arpa.2017-0403-RS","article-title":"Protein C deficiency","volume":"143","author":"Dinarvand","year":"2019","journal-title":"Arch Pathol Lab Med"},{"key":"B17","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1111\/ped.12102","article-title":"Protein C deficiency as the major cause of thrombophilias in childhood: pediatric protein C deficiency","volume":"55","author":"Ohga","year":"2013","journal-title":"Pediatr Int"},{"key":"B18","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1186\/s12887-021-02923-6","article-title":"Severe protein C deficiency in a newborn caused by a homozygous pathogenic variant in the PROC gene: a case report","volume":"21","author":"Song","year":"2021","journal-title":"BMC Pediatr"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2024.1410400\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,23]],"date-time":"2024-12-23T11:12:00Z","timestamp":1734952320000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2024.1410400\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,20]]},"references-count":18,"alternative-id":["10.3389\/fped.2024.1410400"],"URL":"https:\/\/doi.org\/10.3389\/fped.2024.1410400","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,20]]},"article-number":"1410400"}}